{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:48:21Z","timestamp":1780552101200,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.nmd.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T07:21:03Z","timestamp":1714720863000},"page":"20-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Treatment resistance in inclusion body myositis: the role of mast cells"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-7784","authenticated-orcid":false,"given":"I.","family":"Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hilton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Squier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nmd.2024.05.001_bib0001","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.nmd.2024.05.001_bib0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/BOR.0000000000000752","article-title":"Pathogenesis of inclusion body myositis","volume":"32","author":"Greenberg","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"1-2","key":"10.1016\/j.nmd.2024.05.001_bib0003","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","article-title":"Mast cell degranulation activates a pain pathway underlying migraine headache","volume":"130","author":"Levy","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.nmd.2024.05.001_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.npep.2003.12.003","article-title":"Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats","volume":"38","author":"Nimmo","year":"2004","journal-title":"Neuropeptides"},{"issue":"2","key":"10.1016\/j.nmd.2024.05.001_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/neu.2010.1632","article-title":"A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury","volume":"28","author":"Donkin","year":"2011","journal-title":"J Neurotrauma"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0006","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/jcbfm.2009.282","article-title":"Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage","volume":"30","author":"Lindsberg","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0007","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00381-012-1699-7","article-title":"Mast cells in the human dura: effects of age and dural bleeding","volume":"28","author":"Varatharaj","year":"2012","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.nmd.2024.05.001_bib0008","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.102.032797","article-title":"Cellular mechanisms of neurogenic inflammation","volume":"302","author":"Richardson","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.nmd.2024.05.001_bib0009","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00393-020-00951-8","article-title":"Interaction of pain and chronic inflammation","volume":"80","author":"Seifert","year":"2021","journal-title":"Z Rheumatol"},{"issue":"5","key":"10.1016\/j.nmd.2024.05.001_bib0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00186623","article-title":"Inclusion body myositis: clinical and histopathological features of 36 patients","volume":"71","author":"Beyenburg","year":"1993","journal-title":"Clin Investig"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0011","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.nmd.2011.10.023","article-title":"Focal myositis-neurogenic phenomenon?","volume":"22","author":"Lunde","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2024.05.001_bib0012","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2024.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","article-title":"ENMC IBM working group. 188th ENMC international workshop: inclusion body myositis, 2-4 december 2011, Naarden, The Netherlands","volume":"23","author":"Rose","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2024.05.001_bib0014","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","author":"Greenberg","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nmd.2024.05.001_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/WNL.48.1.29","article-title":"Inclusion body myositis: no evidence for a neurogenic component","volume":"48","author":"Luciano","year":"1997","journal-title":"Neurology"},{"issue":"S 1-2","key":"10.1016\/j.nmd.2024.05.001_bib0016","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-510X(00)00395-6","article-title":"Peripheral neuropathy associated with hereditary and sporadic inclusion body myositis: confirmation by electron microscopy and morphometry","volume":"179","author":"Hermanns","year":"2000","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0017","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<480::AID-MUS9>3.0.CO;2-A","article-title":"Quantitative electrophysiologic studies in sporadic inclusion body myositis","volume":"22","author":"Barkhaus","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2024.05.001_bib0018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jelekin.2018.02.003","article-title":"Electromyographic findings in sporadic inclusion body myositis","volume":"39","author":"Nojszewska","year":"2018","journal-title":"J Electromyogr Kinesiol"},{"issue":"6","key":"10.1016\/j.nmd.2024.05.001_bib0019","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.63.6.776","article-title":"The role of quantitative electromyography in inclusion body myositis","volume":"63","author":"Brannagan","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.nmd.2024.05.001_bib0020","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.clinph.2019.08.019","article-title":"Sarcolemmal depolarization in sporadic inclusion body myositis assessed with muscle velocity recovery cycles","volume":"130","author":"Lee","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"10.1016\/j.nmd.2024.05.001_bib0021","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.clinph.2020.07.025","article-title":"Neuropathy in sporadic inclusion body myositis: A multi-modality neurophysiological study","volume":"131","author":"Lee","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0022","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jbspin.2008.10.014","article-title":"Neurogenic muscle hypertrophy","volume":"76","author":"Charlot-Lambrecht","year":"2009","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.nmd.2024.05.001_bib0023","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/ar4512","article-title":"Roles of mast cells in the pathogenesis of inflammatory myopathy","volume":"16","author":"Yokota","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.nmd.2024.05.001_bib0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0960-8966(94)90068-X","article-title":"Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis","volume":"4","author":"Gorospe","year":"1994","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2024.05.001_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0022-510X(95)00255-Z","article-title":"Recruitment of mast cells to muscle after mild damage","volume":"135","author":"Gorospe","year":"1996","journal-title":"J Neurol Sci"},{"issue":"11","key":"10.1016\/j.nmd.2024.05.001_bib0026","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2013-305690","article-title":"Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features","volume":"84","author":"Brady","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T03:15:36Z","timestamp":1722050136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"alternative-id":["S0960896624000981"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.05.001","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment resistance in inclusion body myositis: the role of mast cells","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}